Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

IWMvsXBI

iShares Russell 2000 ETF against SPDR S&P Biotech ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
IWM 117XBI 127Nov 25Nov 26GROWTH OF $100
Head to head
IWMXBI
Expense ratio0.19%0.35%
Assets$76.6B$10.3B
Net flow, 1 month−$4.3B−$8M
Net flow, 1 year−$3.3B+$675M
Return, YTD+10.9%+19.6%
Return, 1 year——
Avg daily volume23.5M9.2M
Holdings1970165
ListedMay 22, 2000Jan 31, 2006
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.